หน้าหลัก

For instance, in China, BRCA1/BRCA2 testing is unnecessary in additional than 80 of socalled highrisk groups. At the moment, there are actually some international models for predicting BRCA1/BRCA2 gene mutations, like the BRCApro, BOADICEA, and Myraid models, of which BRCApro is definitely the most generally used model for familial breast cancer.43 The BOADICEA model may be utilized for both familial breast cancer and agespecific breast cancer in tiny households.44 The Myriad model, developed by Myriad Genetics, Inc. in the United states, is according to information from ten 000 instances of breast/ovarian cancer, such as 2539 Jews.45 In the Italian population, the Myriad model has better sensitivity than the BRCApro model for predicting BRCA1/BRCA2 mutations (89 vs 67 , respectively), and equivalent specificity (51 vs 57 , respectively).46 Thirthagiri et al15 N on the TANK expression constructs tested for their interaction with studied 187 highrisk breast cancer sufferers in Asia (63.1 of whom had been Chinese) and showed that the sensitivity of the BOADICEA prediction model for BRCA1 and BRCA2 mutations was 57 and 9 , respectively. Rao et al47 applied the BRCApro, Penn, and Myriad models to 212 Chinese familial breast cancer sufferers, among whom 33 had BRCA1 or BRCA2 mutations. The sensitivity of your 3 models for predicting BRCA1 mutation was 67 , 13 , and 40 , respectively, when the sensitivity of your BRCApro and Penn models for predicting BRCA2 mutation was 26 and 1 , respectively. Clearly, these models are not suitable for the Chinese population, likely since the penetrance and prevalence parameters of these models have been derived from whites.48 Chen et al incorporated Asianspecific phenocopy rates in to the BRCApro model. The modified model was in a position to predict extra mutations, specifically within the lowest decile, as compared with the unmodified BRCApro model.49 Hence, Rao et al50 established a mutation prediction model according to the characteristics of BRCA1 or BRCA2associated breast cancers inside the ChineseGenBank reference sequences: BRCA1 version #U14680.1; BRCA2 version #U43746.1. b Frequency of recurrent germline mutations in gene total mutations; number of total mutations: 103 in BRCA1, 91 in BRCA2.BRCA1 in 108 highrisk Singaporean Chinese individuals and found large genomic rearrangements in two situations. They then employed the P087 MLPA kit to reanalyze all final results and identified that 1 case was falsepositive and that the other case had a Y of miRK3 with all the sponge construct or deletion of miRK confirmed exon 13 duplication (g.41 220_49682dup8463). Lim et al36 investigated 87 Singapore Chinese ladies at higher risk for breast/ovarian cancers. Exon 13 duplication and exon 4_11a duplication (g.8730_24909dup16180) rearrangements have been detected in BRCA1 and BRCA2, respectively. Kwong et al19,37 studied the Hong Kong Chinese population and found BRCA1 exon 17_20 4987_5277del291, exon 1_12 deletion, and BRCA2 exon 21 8633_8754del112. Kang et al38 studied Chinese Malaysian families and found BRCA1 exon 1_14 deletion in 1 case with hereditary breast/ovarian cancer, with a 78 500 bp deletion. two.3 Noncoding regions and single nucleotide polymorphism There have been reports of mutations in noncoding regions. Wang et al39 reported an 118AT mutation within the 5untranslated region on the BRCA1 gene in sporadic breast cancers. This mutation may possibly downregulate translationalJ Epidemiol 2013;23(two):75Cao W, et al.Table four. Germline mutations of other genes in Chinese with BRCA1/BRCA2negative breast cancerGene TP35 BRIP1 PALB2 CDH1 Location Disease 17p13.1 17q22.two 16p12.1 16q22.1 Li.